HAL vs RNTX · P/E 9.3, $19.05B cap vs $80.6M cap
Halliburton Company (HAL) versus Rein Therapeutics Inc (RNTX) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Rein Therapeutics Inc (RNTX) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported RNTX revenue for 2024-12-31 was $0. Net income was -$62.9M. RNTX currently screens at market cap $80.6M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. RNTX currently screens at market cap $80.6M.
Not investment advice. Open the HAL and RNTX stock pages for the full models.
Not investment advice.